STOCK-BASED COMPENSATION - The 2019 Zyla Plan Narrative (Details)
$ / shares in Units, $ in Millions |
|
12 Months Ended |
|
May 20, 2020
USD ($)
$ / shares
shares
|
Dec. 31, 2021
shares
|
| Zyla Life Sciences |
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
| Merger exchange ratio |
2.5
|
|
| Stock Options |
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
| Vesting period |
|
4 years
|
| The 2019 Zyla Plan | Zyla Life Sciences |
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
| Issued (in shares) |
1,300,000
|
|
| Issued, average fair market value, per share (in dollars per share) | $ / shares |
$ 2.48
|
|
| Issued, value recognized as merger consideration | $ |
$ 0.4
|
|
| The 2019 Zyla Plan | Stock Options |
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
| Number of shares authorized under plan (in shares) |
|
1,246,469
|
| Shares available for future issuance (in shares) |
|
0
|
| The 2019 Zyla Plan | Stock Options | Zyla Life Sciences |
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
| Term of awards (may not exceed) |
10 years
|
|
| Vesting period |
3 years
|
|
| Vesting percentage |
33.00%
|
|
| The 2019 Zyla Plan | Restricted stock units |
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
| Number of units awarded (in shares) |
|
0
|